Physician profile
Michael A Traver
NPI 1740463702
$1,350.05
in general payments reported to CMS, 2019-2025
11 companies · $64.37 in 2025
The $64.37 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $38.24 · 2020: $73.14 · 2021: $98.08 · 2022: $152 · 2023: $871 · 2024: $53.22 · 2025: $64.37.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $512 · Travel and Lodging: $477.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $511.82 |
| Travel and Lodging | $476.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $793.21 | 2019-2025 | Rezum Generator, Spaceoar Vue System - 10ml, Axonics |
| Axonics, INC. | $235.19 | 2020-2024 | Axonics |
| Dornier Medtech America, INC | $134.13 | 2023 | Dornier Medtech |
| Intuitive Surgical, INC. | $53.12 | 2022 | |
| Ethicon US, LLC | $37.43 | 2023-2025 | Echelon; Endopath, Echelon Flex, Vistaseal |
| Olympus America INC. | $20.33 | 2019 | |
| Telix Pharmaceuticals | $19.82 | 2024 | Illuccix |
| Bk Medical Holding Company INC. | $16.19 | 2022 | |
| Merck Sharp & Dohme LLC | $13.94 | 2024 | Bridion |
| Convatec INC. | $13.90 | 2023 | |
| Medtronic, INC. | $12.79 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Traver listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.